Leo Pharma starts study of eczema tablet for nettle rash

Leo Pharma and JW Therapeutics have started a new clinical trial in Germany, testing a tablet that was originally developed for eczema on nettle rash.

Photo: Leo Pharma / PR

Leo Pharma has started expanding the potential span of the eczema tablet which it bought from Korean firm JW Therapeutics in 2018.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs